CAMBRIDGE, Mass. ~ On May 31, 2023, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) granted equity awards to 33 individuals hired by the company in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were approved by the Compensation Committee of Sarepta's Board of Directors under the 2014 Employment Commencement Incentive Plan.

The employees received a total of 19,200 options to purchase shares of Sarepta's common stock at an exercise price of $123.60 per share and 10,000 restricted stock units (RSUs). The options will vest over a four-year period with 1/48th of the shares vesting monthly and the RSUs will vest yearly on each anniversary of the Grant Date.

More on Boston Chron

• Sidow Sobrino Announces 12th Album, "Seminal"
• Boston Public Health Commission Encourages People to Get the Flu Shot Ahead of Flu Season
• Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
• Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
• Massachusetts Wins Proposal to Host Northeast Microelectronics Hub through Federal CHIPS and Science Act

The equity awards were granted as a material inducement to employment and are subject to each employee's continued employment with Sarepta on the vesting dates.

---

Show All News | Report Violation